Red Tortoise LLC’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Red Tortoise LLC’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36	Closed	-$2.12K	–	574
2023 Q4	$2.12K	Hold	36	–	–	﹤0.01%	467
2023 Q3	$1.57K	Buy	+36	New	+$1.28K	﹤0.01%	487

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Red Tortoise LLC's MRTX Position: Q1 2024 in Review

Red Tortoise LLC sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36 shares — an estimated $2.12K sold.

Red Tortoise LLC first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $2.12K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Red Tortoise LLC reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Red Tortoise LLC sold 36 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.12K.
Red Tortoise LLC first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Red Tortoise LLC's Mirati Therapeutics, Inc. Common Stock position peaked at $2.12K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Red Tortoise LLC's 13F filing for Q1 2024, filed 19 Apr 2024.